Concord Biotech (BOM:543960) ROE % Adjusted to Book Value : 2.30% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech ROE % Adjusted to Book Value?

Concord Biotech's ROE % for the quarter that ended in Mar. 2024 was 23.96%. Concord Biotech's PB Ratio for the quarter that ended in Mar. 2024 was 10.43. Concord Biotech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 2.30%.

Concord Biotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Concord Biotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech ROE % Adjusted to Book Value Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

2.10

Concord Biotech Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	-	-	2.45	2.30

Competitive Comparison of Concord Biotech's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Concord Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Concord Biotech's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Concord Biotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Concord Biotech's ROE % Adjusted to Book Value falls into.

Concord Biotech ROE % Adjusted to Book Value Calculation

Concord Biotech's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	21.88%	/	10.43
	=	2.10%

Concord Biotech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	23.96%	/	10.43
	=	2.30%

Concord Biotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Concord Biotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines